DCM
NVCR icon

Dupont Capital Management’s NovoCure NVCR Stock Holding History

Dupont Capital Management’s Portfolio NVCR Stock Details NVCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-3,085
Closed -$232K – 1738
2021
Q4 		$232K Buy
+3,085
New +$310K 0.01% 1075
2020
Q3 		– Sell
-12,275
Closed -$728K – 1404
2020
Q2 		$728K Buy
12,275
+8,708
+244% +$573K 0.02% 627
2020
Q1 		$240K Buy
+3,567
New +$282K 0.01% 953

Other funds holding NVCR

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Dupont Capital Management's NVCR Position: Q1 2022 in Review

Dupont Capital Management sold out of NovoCure (NVCR) in Q1 2022, closing a stake of 3,085 shares — an estimated $232K sold.

Dupont Capital Management first reported a position in NVCR in Q1 2020 and held it in 3 quarters. The position peaked at $728K in Q2 2020. 308 funds tracked by Wall St. Rank hold NVCR as of Q1 2022.

  • Dupont Capital Management reported no remaining NovoCure position as of Q1 2022 after selling out during the quarter.
  • Dupont Capital Management sold 3,085 NovoCure shares in Q1 2022, an estimated $232K.
  • Dupont Capital Management first reported a position in NovoCure in Q1 2020 and held it in 3 quarters.
  • Dupont Capital Management's NovoCure position peaked at $728K in Q2 2020.
  • 308 funds tracked by Wall St. Rank held NovoCure as of Q1 2022.

Based on Dupont Capital Management's 13F filing for Q1 2022, filed 27 Apr 2022.